Assenagon Asset Management S.A. Incyte Corp Transaction History

Assenagon Asset Management S.A.

$54.1 Billion
Q4 2024

A detailed history of Assenagon Asset Management S.A. transactions in Incyte Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 6,428 shares of INCY stock, worth $476,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,428

Previous 6,674 3.69%

Holding current value

$476,700

Previous $441,000 0.45%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$65.08 - $83.38 $16,009 - $20,511	-246 Reduced 3.69%	6,428 $443,000
Q3 2024 Oct 23, 2024	BUY	$57.33 - $68.61 $34,913 - $41,783	609 Added 10.04%	6,674 $441,000
Q2 2024 Jul 18, 2024	SELL	$51.18 - $63.75 $29.3 Million - $36.5 Million	-572,356 Reduced 98.95%	6,065 $367,000
Q1 2024 Apr 24, 2024	SELL	$56.55 - $66.59 $3.18 Million - $3.74 Million	-56,202 Reduced 8.86%	578,421 $33 Million
Q4 2023 Jan 17, 2024	BUY	$52.16 - $64.19 $20.1 Million - $24.7 Million	384,488 Added 153.71%	634,623 $39.8 Million
Q3 2023 Nov 06, 2023	BUY	$57.77 - $65.93 $8.77 Million - $10 Million	151,770 Added 154.29%	250,135 $14.5 Million
Q2 2023 Jul 25, 2023	SELL	$60.95 - $75.51 $746,210 - $924,468	-12,243 Reduced 11.07%	98,365 $6.12 Million
Q1 2023 Apr 18, 2023	SELL	$70.23 - $86.01 $70.9 Million - $86.8 Million	-1,009,382 Reduced 90.12%	110,608 $7.99 Million
Q4 2022 Jan 12, 2023	BUY	$67.18 - $84.11 $48.1 Million - $60.3 Million	716,447 Added 177.54%	1,119,990 $90 Million
Q3 2022 Oct 27, 2022	BUY	$66.18 - $82.86 $13 Million - $16.3 Million	196,587 Added 94.99%	403,543 $26.9 Million
Q2 2022 Jul 27, 2022	BUY	$66.18 - $83.18 $11.6 Million - $14.6 Million	174,954 Added 546.7%	206,956 $15.7 Million
Q1 2022 Apr 25, 2022	SELL	$66.02 - $79.71 $4.08 Million - $4.93 Million	-61,870 Reduced 65.91%	32,002 $2.54 Million
Q4 2021 Feb 01, 2022	BUY	$63.34 - $74.11 $4.71 Million - $5.51 Million	74,341 Added 380.63%	93,872 $6.89 Million
Q3 2021 Oct 19, 2021	SELL	$68.67 - $84.02 $216,035 - $264,326	-3,146 Reduced 13.87%	19,531 $1.34 Million
Q2 2021 Jul 15, 2021	SELL	$79.87 - $87.53 $36.5 Million - $40 Million	-457,352 Reduced 95.28%	22,677 $1.91 Million
Q1 2021 Apr 26, 2021	SELL	$76.02 - $100.5 $6.32 Million - $8.35 Million	-83,099 Reduced 14.76%	480,029 $39 Million
Q4 2020 Feb 01, 2021	BUY	$80.74 - $97.7 $44.7 Million - $54.1 Million	554,239 Added 6235.11%	563,128 $0
Q3 2020 Oct 07, 2020	BUY	$85.07 - $109.69 $310,675 - $400,587	3,652 Added 69.73%	8,889 $798,000
Q2 2020 Jul 21, 2020	BUY	$74.18 - $108.93 $14,910 - $21,894	201 Added 3.99%	5,237 $544,000
Q1 2020 Apr 17, 2020	SELL	$63.18 - $85.97 $7.8 Million - $10.6 Million	-123,386 Reduced 96.08%	5,036 $369,000
Q4 2019 Jan 17, 2020	BUY	$73.04 - $95.72 $9.38 Million - $12.3 Million	128,422 New	128,422 $11.2 Million
Q3 2019 Oct 16, 2019	SELL	$72.82 - $86.52 $4.26 Million - $5.07 Million	-58,564 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$73.52 - $88.7 $4.31 Million - $5.19 Million	58,564 New	58,564 $4.98 Million

Others Institutions Holding INCY

# of Institutions

657

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Incyte Corp Transaction History